Estland - estisk - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 50mg 28tk; 50mg 60tk; 50mg 14tk; 50mg 56tk; 50mg 10tk

Estland - estisk - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 200mg 30tk; 200mg 56tk; 200mg 20tk; 200mg 50tk; 200mg 14tk; 200mg 98tk; 200mg 28tk

Estland - estisk - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 25mg 10tk; 25mg 98tk; 25mg 100tk; 25mg 20tk; 25mg 28tk; 25mg 14tk; 25mg 30tk

Estland - estisk - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 100mg 60tk; 100mg 20tk; 100mg 10tk; 100mg 30tk; 100mg 100tk; 100mg 14tk; 100mg 56tk; 100mg 28tk; 100mg 98tk

Den Europæiske Union - estisk - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Den Europæiske Union - estisk - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Estland - estisk - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk

Estland - estisk - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 56tk

Estland - estisk - Ravimiamet

ideal trade links uab - deksametasoon - tablett - 4mg 28tk; 4mg 56tk; 4mg 100tk

Estland - estisk - Ravimiamet

ideal trade links uab - deksametasoon - tablett - 20mg 10tk; 20mg 50tk; 20mg 30tk; 20mg 20tk